Report Summary
The global biobanking market comprises the revenues generated from products, technologies, software, and services used for the collection, processing, preservation, storage, management, retrieval, transportation, and distribution of biological specimens and associated data for research, clinical, pharmaceutical, biotechnology, diagnostic, and public-health applications.
The Global Biobanking Market was valued at USD 54.60 billion in 2025 and is projected to reach USD 88.78 billion by 2035, expanding at a CAGR of 4.98% during the forecast period. The global biobanking market is primarily driven by the growing adoption of precision medicine and personalized healthcare, which is increasing demand for high-quality, well-characterized biological specimens and associated clinical data. The rapid expansion of pharmaceutical and biotechnology research and development, particularly in genomics, oncology, immunology, cell and gene therapies, and biomarker discovery, is further increasing the need for organized and standardized biospecimen repositories. In addition, the rising prevalence of chronic and complex diseases is encouraging greater investment in disease-specific and population-based biobanks to support long-term research and drug discovery.
The report considers 2021-2024 as historic period, 2025 as base year, and 2026-2035 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Biobanking Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other benchmarking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Biobanking Market Size, 2021-2035 (USD Million)
To learn more about this report
Global Biobanking Market Segmentation:
Biobanking Market, By Product
- Cryogenic Storage Systems
- Alarm & Monitoring Systems
- Media & Consumables
Biobanking Market, By Sample Type
- Blood Products
- Solid Tissues & Organs
- Stem Cells & Cell Lines
- Nucleic Acids
- Biological Fluids
- Human Waste Products
Biobanking Market, By Ownership Type
- Public/Government
- Academic/Non-profit
- Private & Commercial
Biobanking Market, By Application
- Regenerative Medicine
- Drug Discovery
- Disease & Epidemiology Research
- Life-Science & Genomic Research
To learn more about this report
Geographically, the market is categorized into five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Biobanking market in terms of demand generation. The Biobanking market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report includes market size and forecast for the Biobanking market in the countries listed below across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Biobanking Market Taxonomy:
To learn more about this report
Global Biobanking Market Competitive Landscape
The global Biobanking market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Thermo Fisher Scientific Inc.
- Becton, Dickinson & Company
- Merck KGaA
- BioLife Solutions Inc.
- Hamilton Company
- Avantor Inc. (VWR)
- Tecan Group Ltd.
- STEMCELL Technologies
- CENTOGENE N.V.
- Bio-Techne Corp.
- Azenta Life Sciences
- Cryoport Inc.
- QIAGEN N.V.
- BioIVT
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2025 |
USD XX.XX Million |
| CAGR (2026 - 2035) |
XX.XX % |
| The Revenue forecast in 2035 |
USD XX.XX Million |
| Base year for estimation |
2025 |
| Historical data |
2021-2024 |
| Forecast period |
2026-2035 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2026 to 2035
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Product Outlook, Application Outlook, Regional Outlook |
| By Product Outlook |
Cryogenic Storage Systems, Alarm & Monitoring Systems, Media & Consumables |
| By Application Outlook |
Regenerative Medicine, Drug Discovery, Disease & Epidemiology Research, Life-Science & Genomic Research |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Thermo Fisher Scientific Inc., Becton, Dickinson & Company, Merck KGaA, BioLife Solutions Inc., Hamilton Company, Avantor Inc. (VWR), Tecan Group Ltd., STEMCELL Technologies, CENTOGENE N.V., Bio-Techne Corp., Azenta Life Sciences, Cryoport Inc., QIAGEN N.V., BioIVT |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic and non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Biobanking Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Biobanking Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Biobanking Market Performance
2.3 USA Biobanking Market Performance
2.4 Europe Biobanking Market Performance
2.5 Japan Biobanking Market Performance
2.6 Korea Biobanking Market Performance
2.7 India Biobanking Market Performance
2.8 Southeast Asia Biobanking Market Performance
2.9 South America Biobanking Market Performance
3 Global Biobanking Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Biobanking Market Performance (Volume)
3.3 USA Biobanking Market Performance (Volume)
3.4 Europe Biobanking Market Performance (Volume)
3.5 Japan Biobanking Market Performance (Volume)
3.6 Korea Biobanking Market Performance (Volume)
3.7 India Biobanking Market Performance (Volume)
3.8 Southeast Asia Biobanking Market Performance (Volume)
3.9 South America Biobanking Market Performance (Volume)
4 Competitive Analysis
4.1 Beckman Coulter
4.1.1 Beckman Coulter Profiles
4.1.2 Beckman Coulter Product Information
4.1.3 Beckman Coulter Biobanking Production, Revenue, Price and Gross Margin
4.1.4 Beckman Coulter Biobanking Business Performance
4.1.5 SWOT Analysis
4.2 Thermo Fisher
4.2.1 Thermo Fisher Profiles
4.2.2 Thermo Fisher Product Information
4.2.3 Thermo Fisher Biobanking Production, Revenue, Price and Gross Margin
4.2.4 Thermo Fisher Biobanking Business Performance
4.2.5 SWOT Analysis
4.3 Panasonic
4.3.1 Panasonic Profiles
4.3.2 Panasonic Product Information
4.3.3 Panasonic Biobanking Production, Revenue, Price and Gross Margin
4.3.4 Panasonic Biobanking Business Performance
4.3.5 SWOT Analysis
4.4 Sigma-Aldrich
4.4.1 Sigma-Aldrich Profiles
4.4.2 Sigma-Aldrich Product Information
4.4.3 Sigma-Aldrich Biobanking Production, Revenue, Price and Gross Margin
4.4.4 Sigma-Aldrich Biobanking Business Performance
4.4.5 SWOT Analysis
4.5 SOL Group
4.5.1 SOL Group Profiles
4.5.2 SOL Group Product Information
4.5.3 SOL Group Biobanking Production, Revenue, Price and Gross Margin
4.5.4 SOL Group Biobanking Business Performance
4.5.5 SWOT Analysis
4.6 Promega
4.6.1 Promega Profiles
4.6.2 Promega Product Information
4.6.3 Promega Biobanking Production, Revenue, Price and Gross Margin
4.6.4 Promega Biobanking Business Performance
4.6.5 SWOT Analysis
4.7 BD
4.7.1 BD Profiles
4.7.2 BD Product Information
4.7.3 BD Biobanking Production, Revenue, Price and Gross Margin
4.7.4 BD Biobanking Business Performance
4.7.5 SWOT Analysis
4.8 Brooks Life Science
4.8.1 Brooks Life Science Profiles
4.8.2 Brooks Life Science Product Information
4.8.3 Brooks Life Science Biobanking Production, Revenue, Price and Gross Margin
4.8.4 Brooks Life Science Biobanking Business Performance
4.8.5 SWOT Analysis
4.9 QIAGEN
4.9.1 QIAGEN Profiles
4.9.2 QIAGEN Product Information
4.9.3 QIAGEN Biobanking Production, Revenue, Price and Gross Margin
4.9.4 QIAGEN Biobanking Business Performance
4.9.5 SWOT Analysis
4.10 Tecan Group
4.10.1 Tecan Group Profiles
4.10.2 Tecan Group Product Information
4.10.3 Tecan Group Biobanking Production, Revenue, Price and Gross Margin
4.10.4 Tecan Group Biobanking Business Performance
4.10.5 SWOT Analysis
4.11 Lifeline Scientific
4.12 So-Low
4.13 LVL Technologies
4.14 DNA Genotek
4.15 Micronic
4.16 Askion
4.17 Biolife Solutions
4.18 Cryo Bio System
4.19 BioRep
5 Competitive Landscape
5.1 Global Biobanking Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Biobanking Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Biobanking Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Biobanking Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Biobanking Market Assessment by Regions
6.1 Global Biobanking Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Biobanking Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Biobanking Price (USD/Unit) by Regions (2014-2020)
6.4 Global Biobanking Gross Margin by Regions (2014-2020)
7 Biobanking Regional Analysis
7.1 China Biobanking Production, Revenue and Growth Rate (2014-2020)
7.2 USA Biobanking Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Biobanking Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Biobanking Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Biobanking Production, Revenue and Growth Rate (2014-2020)
7.6 India Biobanking Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Biobanking Production, Revenue and Growth Rate (2014-2020)
7.8 South America Biobanking Production, Revenue and Growth Rate (2014-2020)
8 Global Biobanking Consumption Assessment
8.1 Global Biobanking Consumption and Market Share by Regions (2014-2020)
8.2 Global Biobanking Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Biobanking Average Price (USD/Unit) by Regions (2014-2020)
9 Global Biobanking Sales Assessment by Regions
9.1 Global Biobanking Sales and Sales Value (2014-2020)
9.2 China Biobanking Sales and Sales Value (2014-2020)
9.3 USA Biobanking Sales and Sales Value (2014-2020)
9.4 Europe Biobanking Sales and Sales Value (2014-2020)
9.5 Japan Biobanking Sales and Sales Value (2014-2020)
9.6 Korea Biobanking Sales and Sales Value (2014-2020)
9.7 India Biobanking Sales and Sales Value (2014-2020)
9.8 Southeast Asia Biobanking Sales and Sales Value (2014-2020)
9.9 South America Biobanking Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Biobanking Production and Revenue by Regions 2020-2026
12.1.2 China Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.7 India Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Biobanking Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Biobanking Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Biobanking Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Biobanking Sales and Sales Value Forecast 2020-2026
12.2.3 China Biobanking Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Biobanking Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Biobanking Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Biobanking Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Biobanking Sales and Sales Value Forecast 2020-2026
12.2.8 India Biobanking Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Biobanking Sales and Sales Value Forecast 2020-2026
12.2.10 South America Biobanking Sales and Sales Value Forecast 2020-2026
12.3 Global Biobanking Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Equipment
12.3.3 Consumable
12.4 Global Biobanking Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Virtual Biobanks
12.4.3 Tissue Biobanks
12.4.4 Population Biobanks
12.5 Global Biobanking Price and Gross Margin Forecast
13.5.1 Global Biobanking Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Biobanking Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
